Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 3 papers. Top paper: “NRG-DT001 phase Ib trial of neoadjuvant navtemadlin (previously AMG232 and KRT232) concurrent with preoperative radiotherapy in wild-type p53 soft tissue sarcoma of the extremity and body wall.”.
Pedro A. Torres‐Saavedra, Brian Andrew Van Tine, David G. Kirsch, Michelle A. Rudek, Paul E. Wakely +13 more
Alexander Lukez, Elizabeth Henry, Nadine Housri, Brian L. Egleston, Krisha Howell +1 more
Brian L. Egleston, Peter L. Lee, Krisha Howell, Jeremy Price, Alexander Lukez